Showing results (881-890 of 5,009) with videos related to

Sort By:
Pageof 501
American Journal of Clinical Oncology|September 1, 2007
Phase II clinical trial of docetaxel in refractory squamous cell carcinoma of the cervix: a Gynecologic Oncology Group StudyAgustin A Garcia, John A Blessing, Luis Vaccarello, et al.
American Journal of Clinical Oncology|September 1, 2007
Multivitamins do not improve radiation therapy-related fatigue: results of a double-blind randomized crossover trialAngelo Bezerra de Souza Fêde, Carolina Games Bensi, Damila Cristina Trufelli, et al.
American Journal of Clinical Oncology|March 25, 2009
Xerostomia in long-term survivors of aggressive non-Hodgkin's lymphoma of Waldeyer's ring: a potential role for parotid-sparing techniques?Daniel T Chang, Robert J Amdur, Heather Pacholke, et al.
American Journal of Clinical Oncology|March 25, 2009
The influence of intraarterial high-dose cisplatin with concomitant irradiation on arterial microanastomosis: an experimental studyZhong-He Wang, Shi-Zhou Zhang, Zhi-Yuan Zhang, et al.
American Journal of Clinical Oncology|March 25, 2009
Stomal recurrence after total laryngectomy: a clinicopathological multivariate analysisHouyu Zhao, Jie Ren, Xianlu Zhuo, et al.
American Journal of Clinical Oncology|October 7, 2006
The use of complementary and alternative medicine by cancer patients undergoing radiation therapyAnu B Swarup, William Barrett, Abdul Rahman Jazieh
American Journal of Clinical Oncology|October 7, 2006
Clinical outcomes after reirradiation of paraspinal tumorsJean L Wright, D Michael Lovelock, Mark H Bilsky, et al.
American Journal of Clinical Oncology|October 8, 2008
Evaluation of different methods of 18F-FDG-PET target volume delineation in the radiotherapy of head and neck cancerCarlo Greco, Sadek A Nehmeh, Heiko Schöder, et al.
American Journal of Clinical Oncology|October 8, 2008
A phase I study of oral topotecan and pegylated liposomal doxorubicin (doxil) in platinum-resistant ovarian and peritoneal cancerPeter G Rose, Mary Smrekar, Pam Haba, et al.
American Journal of Clinical Oncology|October 8, 2008
A phase II trial of fixed-dosed rate gemcitabine in platinum-resistant ovarian cancer: a GEICO (Grupo Español de Investigación en Cáncer de Ovario) TrialBelen Ojeda Gonzalez, Antonio Gonzalez Martin, Isabel Bover Barcelo, et al.
Pageof 501